Home Compare NOVN.SW vs ORNBV.HE
Stock Comparison · Industry comparison · Drug Manufacturers - General

Novartis vs Orion Oyj: Which Stock Looks Stronger in 2026?

Orion Oyj holds the cleaner structural position, with the lead spread across growth and profitability. Novartis does not offset that deficit through any equally strong structural edge elsewhere. The market setup is broadly comparable for both — no clear directional signal from price behavior. The market is not adding a decisive signal either way — the structural read carries the weight.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The result is anchored in growth, but profitability also reinforces the same direction. Orion Oyj leads by 28 points on the overall comparison score.

INDUSTRY COMPARISON

Both operate in: Drug Manufacturers - General

This comparison is based on industry proximity, not on functional trajectory similarity. NOVN.SW and ORNBV.HE share the same industry classification.

For a similarity-based comparison, see how Novartis and Orion Oyj each position within their functional peer groups in AssetNext.

Peer-Relative Score
NOVN.SW
Novartis AG
55
Peer-Score
Signal qualityHigh
vs
ORNBV.HE
Orion Oyj
83
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The largest gaps do not all point in the same direction.

Dimension spread: NOVN.SW vs ORNBV.HE Profitability 60 100 Stability 78 71 Valuation 55 61 Growth 22 100 NOVN.SW ORNBV.HE
Gap Ranking
#1 Growth +78
#2 Profitability +40
#3 Stability +7
#4 Valuation +6
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for NOVN.SW and ORNBV.HE Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer NOVN.SWORNBV.HE Relative valuation Structural strength

The setup is mixed: neither company clearly combines the stronger profile with the more supportive price setup.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Growth
Orion Oyj ranks near the top of the group on growth; Novartis AG sits in the weaker half.
Profitability
On profitability, the edge is clear — both rank well, but Orion Oyj sits noticeably higher.
Growth — Dominant Gap
NOVN.SW
22
ORNBV.HE
100
Gap+78in favour of ORNBV.HE

Growth adds another layer to the lead, with a very wide gap in revenue growth between the two companies.

What keeps the gap from being one-sided

Stability is the one area where Novartis AG still pushes back materially — it is the steadier name on this dimension, which keeps the result from reading as one-way.

What this means for the comparison

The lead is built on both growth and profitability, making it broader than a single-dimension result.

Explore full peer positioning in AssetNext

Break down the NOVN.SW vs ORNBV.HE comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar growth-driven comparisons

Explore how NOVN.SW and ORNBV.HE each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.